# A Study of LY3045697 in Healthy Participants

> **NCT01750853** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 27 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY3045697
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01750853
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2013-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750853, "A Study of LY3045697 in Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01750853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*